Tocagen is currently evaluating Toca 511 & Toca FC in companion dogs afflicted with brain cancer. If you would like more information about this clinical study, please click here or contact us through the Canine Patient Inquiry Form.
Tocagen is currently evaluating Toca 511 & Toca FC in companion dogs afflicted with brain cancer. If you would like more information about this clinical study, please click here or contact us through the Canine Patient Inquiry Form.